Effectiveness of exhaled nitric oxide for the prediction of non-invasive left atrial pressure in older people : a cross-sectional cohort study
Copyright © 2022, The Authors..
BACKGROUND: During left-sided heart failure (HF), left atrial and pulmonary venous pressure increase, which may lead to pulmonary congestion. Previous cohort studies, examining participants with symptomatic HF or rheumatic heart disease, suggest a relationship between increased left atrial pressure (LAP) and fractional exhaled nitric oxide (FeNO).
AIM: To examine the strength of association between FeNO and echocardiographic assessment of LAP by the E/e' ratio, to determine if FeNO could be used to identify those with elevated LAP.
DESIGN & SETTING: This cross-sectional cohort study examined a subset of the OxVALVE cohort aged ≥65 years. Data collection was undertaken in primary care practices in central England.
METHOD: Each participant underwent a focused cardiovascular history and clinical examination. Standard transthoracic echocardiographic (TTE) assessment was performed on all participants, with the E/e' ratio calculated to obtain a validated surrogate of LAP. FeNO was measured in 227 participants.
RESULTS: FeNO was higher in males compared with females and no different in participants with asthma, chronic obstructive pulmonary disease (COPD), or those using inhaled steroids. Participants with a high E/e' (>14) were older, with a higher proportion of females than males. There was no relationship between E/e' and FeNO, either when measured as a continuous variable or in the group with high E/e'.
CONCLUSION: FeNO was not found to be an accurate predictor of elevated LAP in a primary care setting.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
BJGP open - 7(2023), 1 vom: 01. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jones, Samuel Thomas [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiology |
---|
Anmerkungen: |
Date Revised 21.07.2023 published: Electronic-Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3399/BJGPO.2022.0105 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348467877 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM348467877 | ||
003 | DE-627 | ||
005 | 20231226040307.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3399/BJGPO.2022.0105 |2 doi | |
028 | 5 | 2 | |a pubmed24n1161.xml |
035 | |a (DE-627)NLM348467877 | ||
035 | |a (NLM)36332908 | ||
035 | |a (PII)BJGPO.2022.0105 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jones, Samuel Thomas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effectiveness of exhaled nitric oxide for the prediction of non-invasive left atrial pressure in older people |b a cross-sectional cohort study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 21.07.2023 | ||
500 | |a published: Electronic-Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2022, The Authors. | ||
520 | |a BACKGROUND: During left-sided heart failure (HF), left atrial and pulmonary venous pressure increase, which may lead to pulmonary congestion. Previous cohort studies, examining participants with symptomatic HF or rheumatic heart disease, suggest a relationship between increased left atrial pressure (LAP) and fractional exhaled nitric oxide (FeNO) | ||
520 | |a AIM: To examine the strength of association between FeNO and echocardiographic assessment of LAP by the E/e' ratio, to determine if FeNO could be used to identify those with elevated LAP | ||
520 | |a DESIGN & SETTING: This cross-sectional cohort study examined a subset of the OxVALVE cohort aged ≥65 years. Data collection was undertaken in primary care practices in central England | ||
520 | |a METHOD: Each participant underwent a focused cardiovascular history and clinical examination. Standard transthoracic echocardiographic (TTE) assessment was performed on all participants, with the E/e' ratio calculated to obtain a validated surrogate of LAP. FeNO was measured in 227 participants | ||
520 | |a RESULTS: FeNO was higher in males compared with females and no different in participants with asthma, chronic obstructive pulmonary disease (COPD), or those using inhaled steroids. Participants with a high E/e' (>14) were older, with a higher proportion of females than males. There was no relationship between E/e' and FeNO, either when measured as a continuous variable or in the group with high E/e' | ||
520 | |a CONCLUSION: FeNO was not found to be an accurate predictor of elevated LAP in a primary care setting | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a cardiology | |
650 | 4 | |a family practice | |
650 | 4 | |a general practice | |
650 | 4 | |a heart failure | |
650 | 4 | |a primary health care | |
700 | 1 | |a Londahl, Monica |e verfasserin |4 aut | |
700 | 1 | |a Prothero, Anthony |e verfasserin |4 aut | |
700 | 1 | |a Hobbs, Fd Richard |e verfasserin |4 aut | |
700 | 1 | |a Pavord, Ian |e verfasserin |4 aut | |
700 | 1 | |a Myerson, Saul G |e verfasserin |4 aut | |
700 | 1 | |a Prendergast, Bernard D |e verfasserin |4 aut | |
700 | 1 | |a Coffey, Sean |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BJGP open |d 2017 |g 7(2023), 1 vom: 01. März |w (DE-627)NLM29194342X |x 2398-3795 |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2023 |g number:1 |g day:01 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.3399/BJGPO.2022.0105 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2023 |e 1 |b 01 |c 03 |